The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation
Open accessAbstract
BACKGROUND: Whether transcatheter mitral-valve repair improves outcomes in patients with heart failure and functional mitral regurgitation is uncertain. METHODS: We conducted a randomized, controlled trial involving patients with heart failure and moderate to severe functional mitral regurgitation from 30 sites in nine countries. The patients were assigned in a 1:1 ratio to either transcatheter mitral-valve repair and guideline-recommended medical therapy (device group) or medical therapy alone (control group). The three primary end points were the rate of the composite of first or recurrent hospitalization for heart failure or cardiovascular death during 24 months; the rate of first or recurrent hospitalization for heart failure during 24 months; and the change from baseline to 12 months in the score on the Kansas City Cardiomyopathy Questionnaire-Overall Summary (KCCQ-OS; scores range from 0 to 100, with higher scores indicating better health status). RESULTS: A total of 505 patients underwent randomization: 250 were assigned to the device group and 255 to the control group. At 24 months, the rate of first or recurrent hospitalization for heart failure or cardiovascular death was 37.0 events per 100 patient-years in the device group and 58.9 events per 100 patient-years in the control group (rate ratio, 0.64; 95% confidence interval [CI], 0.48 to 0.85; P = 0.002). The rate of first or recurrent hospitalization for heart failure was 26.9 events per 100 patient-years in the device group and 46.6 events per 100 patient-years in the control group (rate ratio, 0.59; 95% CI, 0.42 to 0.82; P = 0.002). The KCCQ-OS score increased by a mean (±SD) of 21.6±26.9 points in the device group and 8.0±24.5 points in the control group (mean difference, 10.9 points; 95% CI, 6.8 to 15.0; P<0.001). Device-specific safety events occurred in 4 patients (1.6%). CONCLUSIONS: Among patients with heart failure with moderate to severe functional mitral regurgitation who received medical therapy, the addition of transcatheter mitral-valve repair led to a lower rate of first or recurrent hospitalization for heart failure or cardiovascular death and a lower rate of first or recurrent hospitalization for heart failure at 24 months and better health status at 12 months than medical therapy alone. (Funded by Abbott Laboratories; RESHAPE-HF2 ClinicalTrials.gov number, NCT02444338.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017
Self-citationPercutaneous Repair or Surgery for Mitral Regurgitation
Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., Smalling, R. W., Siegel, R., Rose, G. A., Engeron, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009355 · Cited by 2,183
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
Obadia, J.-F., Messika-Zeitoun, D., Leurent, G., Iung, B., Bonnet, G., Piriou, N., Lefèvre, T., Piot, C., Rouleau, F., Carrié, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805374 · Cited by 1,806
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.011 · Cited by 931
Proportionate and Disproportionate Functional Mitral Regurgitation
Grayburn, P. A., Sannino, A., & Packer, M. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2018.11.006 · Cited by 651
Lancellotti, P., Pibarot, P., Chambers, J., Edvardsen, T., Delgado, V., Dulgheru, R., Pepi, M., Cosyns, B., Dweck, M. R., Garbi, M., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew025 · Cited by 567
Self-citationAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3024 · Cited by 466
Self-citationFive-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation
Stone, G. W., Abraham, W. T., Lindenfeld, J., Kar, S., Grayburn, P. A., Lim, D. S., Mishell, J. M., Whisenant, B., Rinaldi, M., Kapadia, S. R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2300213 · Cited by 369
Self-citationStone, G. W., Vahanian, A. S., Adams, D. H., Abraham, W. T., Borer, J. S., Bax, J. J., Schofer, J., Cutlip, D. E., Krucoff, M. W., Blackstone, E. H., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.046 · Cited by 239
Self-citationPercutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 Years
Iung, B., Armoiry, X., Vahanian, A., Boutitie, F., Mewton, N., Trochu, J.-N., Lefèvre, T., Messika-Zeitoun, D., Guerin, P., Cormier, B., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1616 · Cited by 231
Self-citationMITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results
Pibarot, P., Delgado, V., & Bax, J. J. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez073 · Cited by 218
Transcatheter Mitral Valve Therapy in the United States
Mack, M., Carroll, J. D., Thourani, V., Vemulapalli, S., Squiers, J., Manandhar, P., Deeb, G. M., Batchelor, W., Herrmann, H. C., Cohen, D. J., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.058 · Cited by 180
Adamo, M., Chioncel, O., Benson, L., Shahim, B., Crespo‐Leiro, M. G., Anker, S. D., Coats, A. J. S., Filippatos, G. S., Lainščak, M., McDonagh, T. A., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2929 · Cited by 83
Self-citationPacker, M., & Grayburn, P. A. (2019) · Circulation · doi:10.1161/circulationaha.119.039612 · Cited by 78
Stolz, L., Doldi, P. M., Orban, M., Karam, N., Puscas, T., Wild, M. G., Popescu, A., von Bardeleben, R. S., Iliadis, C., Baldus, S. E., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.10.032 · Cited by 71
Self-citationHospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure
Giustino, G., Camaj, A., Kapadia, S. R., Kar, S., Abraham, W. T., Lindenfeld, J. M., Lim, D. S., Grayburn, P. A., Cohen, D. J., Redfors, B., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.803 · Cited by 58
Self-citationThe Evolving Concept of Secondary Mitral Regurgitation Phenotypes
Stolz, L., Doldi, P. M., Sannino, A., Hausleiter, J., & Grayburn, P. A. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.01.012 · Cited by 54
Anker, S. D., Friede, T., von Bardeleben, R. S., Butler, J., Khan, M. S., Diek, M., Heinrich, J., Geyer, M., Placzek, M., Ferrari, R., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3286 · Cited by 41
Self-citationAnker, S. D., Friede, T., von Bardeleben, R. S., Butler, J., Fatima, K., Diek, M., Heinrich, J., Hasenfuss, G. P., Schillinger, W., & Ponikowski, P. P. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3247 · Cited by 24
Self-citationUsing multiple primary endpoints in clinical trials with a focus on heart failure
Anker, S. D., Butler, J., Talha, K. M., & Friede, T. (2024) · Global Cardiology · doi:10.4081/cardio.2024.33 · Cited by 23
Self-citationManagement of secondary mitral regurgitation: from drugs to devices
Barnes, C., Sharma, H. C., Gamble, J. H. P., & Dawkins, S. (2023) · Heart · doi:10.1136/heartjnl-2022-322001 · Cited by 17
Cited by
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
Self-citation
Metadata
- Authors
- Anker, S. D., Friede, T., von Bardeleben, R.-S., Butler, J., Khan, M.-S., Diek, M., Heinrich, J., Geyer, M., Placzek, M., Ferrari, R., Abraham, W. T., Alfieri, O., Auricchio, A., Bayes-Genis, A., Cleland, J. G. F., Filippatos, G., Gustafsson, F., Haverkamp, W., Kelm, M., Kuck, K.-H., Landmesser, U., Maggioni, A. P., Metra, M., Ninios, V., Petrie, M. C., Rassaf, T., Ruschitzka, F., Schäfer, U., Schulze, P. C., Spargias, K., Vahanian, A., Zamorano, J. L., Zeiher, A., Karakas, M., Koehler, F., Lainscak, M., Öner, A., Mezilis, N., Theofilogiannakos, E. K., Ninios, I., Chrissoheris, M., Kourkoveli, P., Papadopoulos, K., Smolka, G., Wojakowski, W., Reczuch, K., Pinto, F. J., Wiewiórka, Ł., Kalarus, Z., Adamo, M., Santiago-Vacas, E., Ruf, T. F., Gross, M., Tongers, J., Hasenfuss, G., Schillinger, W., & Ponikowski, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2024-11-14
- Volume
- 391
- Issue
- 19
- Pages
- 1799-1809
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4402092075
- Cited by
- 275
- References
- 22
- FWCI
- 73.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.